经导管动脉硬化栓塞联合口服普萘洛尔治疗婴儿巨大血管瘤

摘要

目的 探讨经导管动脉硬化栓塞(TASE)联合口服普萘洛尔治疗普通婴儿巨大血管瘤的临床疗效与安全性.方法 对76例普通婴儿巨大血管瘤患儿行TASE联合口服酱萘洛尔治疗,于末次治疗后进行疗效评价,分析并发症发生情况.结果 对76例患儿共行TASE共95例次,穿刺技术成功率为100％(95/95).76例患儿中,Ⅰ级预后6例(6/76,7.90％),Ⅱ级19例(19/76,25.00％),Ⅲ级23例(23/76,30.26％),Ⅳ级28例(28/76,36.84％),总有效率100％(76/76).随访发现疗效稳定,无严重并发症发生.结论 TASE联合口服普萘洛尔治疗婴儿巨大血管瘤疗效确切,且创伤小、并发症少.%Objective To evaluate the therapeutic effects and safety of transcatheter arterial sclerosing embolization (TASE) combined with oral Propranolol in infantile huge hemangiomas.Methods A total of 76 infants with huge hemangioma were treated by TASE.All patients received oral Propranolol based on their weight.The follow-up and efficacy evaluation were performed from the last treatment.And the complications were analyzed.Results Seventy-six cases underwent 95 case-times of TASE totally.The success rate of puncture technique was 100％ (95/95).All patients were divided into 5 levels (0-Ⅳ levels) based on the curative effect of the follow-up,including 6 cases (6/76,7.90％) of level Ⅰ,19 cases (19/76,25.00％) of level Ⅱ,23 cases (23/76,30.26％) of level l,and 28 cases (28/76,36.84％) of level Ⅳ.The total effective rate was 100％ (76/76).There was no serious complications,and the curative effect was stable during the follow-up.Conclusion TASE combined with oral Propranolol in infantile huge hemangiomas is effective with less invasiveness and fewer complications.